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Purpose of review: To provide an overview of the transplant component of the Canadian Organ Replacement
Register (CORR).
Findings: CORR is the national registry of organ failure in Canada. It has existed in some form since 1972 and currently
houses data on patients with end-stage renal disease and solid organ transplants (kidney and/or non-kidney). The
transplant component of CORR receives data on a voluntary basis from individual transplant centres and organ
procurement organizations across the country. Coverage for transplant procedures is comprehensive and complete.
Long-term outcomes are tracked based on follow-up reports from participating transplant centres. The longitudinal
nature of CORR provides an opportunity to observe the trajectory of a patient’s journey with organ failure over their life
span. Research studies conducted using CORR data inform both practitioners and health policy makers alike.
Implications: The importance of registry data in monitoring and improving care for Canadian transplant candidates/
recipients cannot be over-stated. This paper provides an overview of the transplant data in CORR including its history,
data considerations, recent findings, new initiatives, and future directions.
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But de la revue: Offrir un aperçu du volet « transplantation d’organes » du Registre canadien des insuffisances et
des transplantations d’organes (RCITO).
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Résultats: Le RCITO est le Registre canadien des insuffisances d’organes au Canada. Il a commencé à prendre
forme en 1972, et contient à l’heure actuelle des données sur des patients atteints de néphropathie terminale et
sur des transplantations (rénales ou non rénales) d’organes pleins. Le volet « transplantation d’organes » du RCITO
collige des données qui ont été envoyées, sur une base volontaire, par des centres de transplantation et des
services d’approvisionnement en organes à travers le pays. Le Registre offre une couverture exhaustive et complète
des différentes interventions de transplantation. Les résultats à long terme sont retracés à partir de rapports de
rendez-vous de suivi des centres de transplantation participants. L’ampleur longitudinale du RCITO offre la possibilité
d’observer le parcours, tout au long de sa vie, du patient atteint d’une insuffisance organique. Les études produites à
partir des données du RCITO éclairent à la fois les praticiens et les décideurs du domaine de la santé.
Implications: On ne peut surestimer l’importance des données du Registre lorsqu’il s’agit d’effectuer le suivi des
candidats canadiens potentiels à une transplantation, ou d’améliorer les soins qui leur sont offerts.
Cette revue offre un aperçu des données du RCITO qui se rapportent à la transplantation d’organes, dont : l’historique,
les éléments à considérer sur les données, des résultats récents, de nouvelles initiatives et les orientations futures.What was known before
The Canadian Organ Replacement Register (CORR) is the
national registry of organ failure and contains information
on dialysis, donation, and organ transplantation in Canada.
However, the details of CORR’s transplant data holdings
and the future directions of the registry are not widely
known.What this adds
This review provides a description of CORR, its transplant-
related data holdings, the results of analyses using these
data, and the future direction of the registry.Background
The Canadian Organ Replacement Register (CORR) is
the national registry for organ failure in Canada. The
scope of CORR includes all incident and prevalent end-
stage kidney disease (ESKD) patients on dialysis, organ
donors (deceased and living), and recipients of kidney
and/or non-kidney organ transplants. CORR is a lon-
gitudinal database, i.e., all kidney patients are tracked
from the time of dialysis initiation or transplantation to
dialysis modality switches, organ failure, and/or death.
Non-kidney solid organ transplant patients are tracked
from the time of transplantation. The CORR Board of
Directors (comprised of physicians, surgeons, allied
health professionals, data scientists, patient advocates,
and patients) is responsible for providing strategic advice
to the CORR team at the Canadian Institute for Health
Information (CIHI). CIHI oversees CORR operations
including data collection, management, analytics, and
reporting.
This report provides an overview of the transplanta-
tion component of CORR. A detailed review of the dialy-
sis component of CORR has also been published [1].History
CORR originally started as a renal failure registry in
1972 under the leadership of Dr. Arthur Shimizu [2]. In
1973, the registry transferred to Statistics Canada, in
collaboration with the Kidney Foundation of Canada. Its
first report was published in 1974, and in subsequent
years, more detailed reports of dialysis and kidney trans-
plantation activity were produced. In 1980, CORR de-
veloped a new partnership with the Kidney Foundation
of Canada, Health Canada, and Statistics Canada, with
guidance from the Canadian Society of Nephrology. In-
formation on extra-renal solid organ transplants became
a part of CORR’s data holdings in 1987. This was initi-
ated after the Advisory Committee on Institutional and
Medical Services made a recommendation in 1985 that
CORR become a fully functional organ failure registry.
Data on extra-renal solid organ transplants performed
prior to 1987 were also retroactively collected, although
not systematically. Prospective data collection on all inci-
dent extra-renal solid organ transplants started on January
1, 1988. All kidney transplants in patients initiating renal
replacement therapy in Canada from January 1, 1981 on-
ward are captured in CORR.Methods
Data considerations
Data for the transplant portion of CORR are voluntarily
submitted to CIHI by all Canadian transplant centres,
either directly or through their provincial and regional
organ procurement organization (OPO). A total of 25
kidney, 9 liver, 11 heart, 6 lung, 8 pancreas, 3 intestinal/
multi-visceral, and 2 islet transplant programs are repre-
sented in CORR. Data submission occurs twice a year.
After the completion of data entry at CIHI, reporting
centres are provided standardized audit reports for the
purposes of data verification. At present, the CORR
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year-end and the CORR annual analytical report is
published within 11 months following data year-end.
Only transplants performed in Canada are reported by
CORR. However, out-of-country transfers are also cap-
tured when reported by transplant facilities.
Newly transplanted patients are reported to CORR via
organ-specific registration forms. This includes baseline
demographic and clinical information as well as events in
the early post-transplant period (e.g., delayed graft func-
tion in kidney transplant recipients). Forms detailing the
characteristics of deceased and living donors are typically
completed by the OPO and transplant centres, respec-
tively. Follow-up events, including return to dialysis,
re-transplantation, graft failure, or death, are reported to
CORR using the follow-up or outcome forms for each
organ transplant group. Coverage of transplant procedures
in CORR has been evaluated against the CIHI Discharge
Abstract Database and found to have 98.5% agreement
despite voluntary reporting by transplant centres [2]. The
completeness of follow-up data in CORR has not under-
gone a similar validation process. Moreover, certain data
elements have historically displayed greater degrees of
missingness (e.g., race/ethnicity, cause of death, cause of
graft failure) than other data elements [2]. Further details
on CORR data quality can be found in Appendix D of the
2014 CORR Annual Report (www.cihi.ca/corr). All of the
CORR reporting forms for 2014 are provided in the
Additional file 1. Each data element is explicitly defined in
a CORR instruction manual provided by CIHI to all par-
ticipating centres.
CORR does not currently receive patient-level data for
those wait-listed for transplantation. Aggregate counts of
patients waiting for solid organ transplants are provided
on a semi-annual basis by the OPO responsible for main-
taining these waiting lists. This allows for the tracking of
total numbers of patients on the waiting list at the end of
each calendar year as well as the number of deaths over
the year. The OPO contributing wait-list counts in-
clude BC Transplant, Southern Alberta Organ and Tissue
Donation Program (Calgary), HOPE Edmonton, the
Saskatchewan Transplant Program (Saskatoon and Regina),
Transplant Manitoba Gift of Life, the Trillium Gift of Life
Network (Ontario), Transplant Québec and the Nova
Scotia Multi-Organ Transplant Program (for the Atlantic
region). A recent effort to collect patient-level data from
the time of referral to transplantation has been under-
taken in the ESKD population (see below).
Results
Organ donation in Canada
In CORR, deceased organ donors are defined as donors
from whom at least one organ was recovered and trans-
planted. This definition is more conservative than thatused by the Organ Procurement and Transplantation
Network (U.S.) and Eurotransplant (Europe), which in-
cludes donors whose organs were recovered, but not
transplanted. This is an important distinction to con-
sider when making comparisons of deceased donor rates
between countries. Moreover, CORR’s definition pre-
cludes the ability to quantify rates of organ discard from
donors whose organs were recovered but not used.
The deceased donation rate has shown steady improve-
ment in Canada, rising from 12.9 per million population
(PMP) in 2002 to 15.5 PMP in 2012 (Figure 1) with gains in
donors from neurological determination of death (NDD)
and donation after cardio-circulatory death (DCD). DCD
have doubled from 40 donors in 2008 to 82 donors in
2012 and currently makes up 14% of total deceased dona-
tions (target 25%). The living donor rate has been stable
over the last 10 years; in 2012, the living and deceased do-
nation rates were the same (i.e., 15.5 PMP).
A closer look at the general increase in Canadian de-
ceased donation activity shows that certain regions such
as Quebec, Ontario, B.C., and Atlantic Canada have made
and sustained modest gains over the last 10 years while
other provinces have remained stable in their activity or
have shown some decline (Table 1). Specifically, Nova
Scotia and Newfoundland have achieved over 22 donors
PMP, which is the deceased donor performance target
reported in the 2011 Call to Action report [3]. There were
540 deceased donors and 539 living donors in 2012; it
is the first time that the former has exceeded the latter
(Figure 2). This translated into 1,686 deceased and 539
living donor kidney and/or non-kidney transplants in
2012. This represents a 25% increase in deceased donor
transplants and a 22% increase in living donor transplants
when compared to 2002 (Figure 3). During this time, the
rate of organ utilization per deceased donor has remained
stable for kidneys, livers, hearts, and lungs (Figure 4).
Solid organ transplantation in Canada
Kidney transplantation
There were 3,428 prevalent kidney transplant candidates
on the waiting list by the end of 2012, a 13.7% increase
from 2001. Despite this growth in the prevalent waiting
list, the mortality rate of kidney transplant candidates
has remained stable at 2 to 3% per year (Additional file 1:
Figure S1). The record number of wait-listed candidates
was mirrored by the number of kidney transplants per-
formed in 2012. A total of 1,245 patients received a kidney
transplant in 2012, with an approximately 2/3 to 1/3 dis-
tribution of deceased to living donors. This represents an
increase of 24.6% in kidney transplant activity from 2003
to 2012 (Additional file 1: Table S1). A total of 72 kidneys
were simultaneously transplanted with non-kidney organs
(other than pancreas) from 2003 to 2012. There has been
no clear trend in this activity over time, with 5 to 11
Figure 1 Canadian donor rate per million population by donor type.
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file 1: Table S1).
Kidney transplant outcomes are excellent, with 1- and
5-year total graft survival (where graft failure is defined as
return to dialysis, pre-emptive kidney transplant, or death
with graft function) of 93.4% and 81.8% in deceased donor
kidney transplants and 97.1 and 90.0% in living donor kid-
ney transplants, respectively (Additional file 1: Figure S2).
Death-censored graft survival at 1- and 5-years for de-
ceased donor kidney transplants are 95.6% and 88.9%
while living donor kidney transplants are 97.7% and
93.4%, respectively (Additional file 1: Figure S3). From
2003 to 2012, outcomes have modestly improved for
deceased donor kidney transplants and remained stable
for living donor kidney transplants (Additional file 1:
Figures S4 to S7).
Liver transplantation
At the end of 2012, 492 patients were awaiting a liver
transplant. Over the last decade, the year with the largest
waiting list was 2006 at 723 patients (Additional file 1:Table 1 Deceased donor rate (Per Million Population) by regi
2002 2003 2004 2005 2
Canada 12.9 13.3 12.9 12.7 1
Province B.C. 7.3 9.4 7.4 5.9 8
Alta. 17.3 11.4 16.2 14.1 1
Sask. 12.0 17.1 9.0 15.1 1
Man. 9.5 10.3 6.0 5.1 1
Ont. 11.3 11.6 12.3 11.8 1
Que. 16.8 19 18 17.8 1
N.B. 14.7 16 13.3 21.3 1
N.S./P.E.I. 11.8 11.8 9.6 13.9 2
N.L. 27.0 19.3 9.7 13.6 2Figure S8). Mortality rates on the liver transplant waiting
list are 15 to 20% per year and have remained relatively
stable. A total of 494 patients received a liver transplant
in 2012, a 22.0% increase since 2003 (Additional file 1:
Table S2). Living donor liver transplants represent about
16% of the total activity. The cumulative survival of liver
transplant recipients ranges from 81.8 to 87.0% in the
first year after liver transplant (as a function of age
group) to 74.0 to 82.0% by the end of the fifth year post-
transplant (Additional file 1: Figure S9). There has been
little difference in the outcomes of deceased and living
donor liver transplantation, although the cumulative
survival of living donor liver recipients is numerically
superior to deceased donor liver recipients (Additional
file 1: Figure S10). Short and long-term liver transplant
outcomes have shown an improving trend from 2003 to
2012 (Additional file 1: Figure S11).
Heart transplantation
There has been a steady rise in the number of patients
wait-listed for a heart transplant in Canada over the laston
006 2007 2008 2009 2010 2011 2012
4.1 14.7 14.4 14.4 13.6 14.9 15.5
.4 8.8 12.3 7.2 10.8 12.2 15.1
4.8 13.7 11.4 10.6 8.9 10.3 10.1
0.1 14 12.8 12.6 12.5 12.3 5.6
1.0 12.6 11.6 11.5 15.4 7.2 9.5
3.6 15.5 13.6 16.7 15.1 16.3 18.7
8.2 18.2 19.5 17.6 15.1 17.2 14.9
3.3 17.4 10.7 14.7 10.6 9.3 15.9
0.3 15 17.1 16 20.1 26.4 15.5
3.5 9.9 15.8 13.8 9.8 19.6 23.4
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Living 441 435 475 504 556 554 546 516 557 521 539








Figure 2 Total number of Canadian donors by donor type.
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for a heart transplant, whereas 125 patients were waiting
at the end of 2001 (Additional file 1: Figure S12). This rep-
resents a 46% increase in wait-list activity. There were 161
heart transplants performed in 2012 with 11% of reci-
pients in the pediatric category (i.e., age 0 to 17 years).
The peak year for transplant activity over the last decade
was 2006 with 178 heart transplants (Additional file 1:
Table S3). Notably, a marked decline in wait-list mortality
has been observed over the last several years, from 32% in
2001 to 9% in 2012. The cumulative survival of heart
transplant recipients ranges from 77.9 to 88.6% at 1-year
and 75.0 to 83.9% at 5-years, depending on recipient age
category (Additional file 1: Figure S13). There has been a
trend toward improving heart transplant survival, at least
to 3-years post-transplant (Additional file 1: Figure S14).2002 2003 2004 2005 2006
Living 441 435 472 502 555







Figure 3 Total number of Canadian solid organ transplant recipientsSome of the trends observed could be explained by in-
creased utilization of Ventricular Assist Devices (VAD)
[4], which may increase the number of patients surviving
on the waiting list. Paradoxically, it may also help ex-
plain the decrease in the number of heart transplants, as
programs can now wait longer for better quality and
matched organs, while patients are supported by VADs.
Currently, data on VAD utilization are not captured by
CORR.
Lung transplantation
Like heart transplantation, there has been a progressive
increase in the number of prevalent wait-listed lung
transplant candidates over the last decade. At total of
315 patients were waiting for a lung transplant at the
end of 2012. This represents a 93% increase since 2001.2007 2008 2009 2010 2011 2012
554 546 516 557 521 539
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Figure 4 Organ utilization for transplantation among deceased donors by year.
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plant candidates remains high, ranging from 18 to 24%
over the last decade (Additional file 1: Figure S15). With
the increasing number of patients waiting for a lung
transplant, there has also been an increase in the number
of lung transplant procedures. In 2012, a total of 191 lung
transplants were performed, which is the most in a single
year over the prior decade (Additional file 1: Table S4).
The vast majority of these transplants were bilateral lung
procedures (157 of 191 in 2012) and this pattern persisted
over the last decade (Additional file 1: Table S5). The
1- and 5-year cumulative survival probabilities after lung
transplantation range from 82.8 to 88.3% and 63.0 to
66.1%, depending on recipient age category (Additional
file 1: Figure S16). Marked improvements in both short
and long-term lung transplant survival have been ob-
served from 2003 to 2012 (Additional file 1: Figure S17).
Kidney-pancreas and islet transplantation
The prevalent population of wait-listed kidney-pancreas
transplant candidates has seen some fluctuations over
the last decade but, in general, there has been approxi-
mately 100 to 130 patients awaiting transplantation at
the end of most years (122 patients at the end of 2012).
The wait-list mortality rate saw an unexplained increase
from its baseline of 2 to 5% to 15% in 2010 and 2011.
The most recent year showed a return to the baseline
mortality rate of 2% (Additional file 1: Figure S18). This
baseline reflects what has been historically observed in
kidney transplant candidates. There were 77 kidney-
pancreas transplants in 2012, which represents a 20%
increase from 2003. Islet transplants have also seen a
record year with 62 procedures in 2012, up from 35 in
2003 (Additional file 1: Table S6). The 1- and 5-year cu-
mulative survival probabilities after kidney-pancreas
transplantation range from 90.3 to 97.7% and 86.7 to88.8%, depending on recipient age category (Additional
file 1: Figure S19). The survival of kidney-pancreas
transplants has not shown consistent trends over time
but this may at least partially reflect the small numbers
of transplants especially in the earlier era (Additional
file 1: Figure S20).
Intestinal and multi-visceral transplantation
Intestinal and multi-visceral transplants are generally
uncommon with a total of 34 procedures performed
from 2003 to 2012. Slightly over half of these transplants
(i.e., 18 of 34) have been performed in children under
the age of 18 years. Most intestinal transplants have
been performed in conjunction with a liver (11 from
2003 to 2012). Multi-visceral transplants represent a
total of 11 procedures during the same time period
(Additional file 1: Table S7).
Access to kidney transplantation feasibility project
In June 2010, the CORR Board, in partnership with CIHI,
initiated data collection on all newly referred ESKD pa-
tients at 16 of 18 adult kidney transplant centres across
Canada. This project is called the “Access to Kidney
Transplantation Feasibility Project” and is supported by
an unrestricted grant from Roche Canada. The objectives
are to gain insights into the types of ESKD patients being
referred to kidney transplant centres across Canada, assess
the timeliness and effectiveness of wait-listing practices,
and track the outcomes of patients wait-listed for de-
ceased donor kidney transplantation. Patients have been
recruited for a 3-year period (until May 2013) and 2-years
of additional follow-up are ongoing. Over 7,000 patients
have been recruited into this study (Table 2). Data on
wait-listed kidney transplant candidates are collected in
other national registries (e.g., the U.S. Scientific Registry of
Transplant Recipients) but this project is the first to
Table 2 Baseline characteristics of patient referred for
kidney transplantation
Patient characteristics at referral Summary measure
Total sample size 7,409
Age (mean, years) 52.3








Valid HCN (%) 99.6
Valid postal code (%) 98.6
On dialysis (%) 60.5
Not on dialysis, SCr (mean, μmol/L) 383.4
Not on dialysis, SCr missing (%) 7.9
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comes to completion, a number of analyses are planned
with the goal of publishing the findings in peer-reviewed
journals.
Transplantation research using CORR
When a PubMed search of the terms “Canadian Organ
Replacement Register” or “Canadian Organ Replacement
Registry” and “transplantation” or “transplant” (as a
MeSH or key word) was performed on 1 Sep 2014, a
total of 49 citations were retrieved. Among these cita-
tions, 34 were transplant-related studies/reports using
CORR data. Eight additional papers (seven original arti-
cles and one commentary) were retrieved from the lead
author’s files, resulting in a total of 42 publications (see
the full list of citations in the Additional file 1). Over
half of the papers (n = 25) related to kidney transplan-
tation, while a smaller number of publications focused
on extra-renal transplants (n = 9), deceased organ dona-
tion (n = 1), and general reports on ESKD and/or trans-
plantation in Canada (n = 7).
Along with studies that highlighted trends in transplan-
tation in Canada, the availability of registries from other
countries have allowed for international comparative ana-
lyses. For example, the mortality of kidney transplant re-
cipients in Canadian vs. U.S. patients was investigated
using data from CORR and the U.S. Scientific Registry of
Transplant Recipients [5]. This study revealed that U.S.
patients were 35% more likely to die after kidney trans-
plantation than their Canadian counterparts. This morta-
lity difference was further accentuated the longer patients
were on dialysis before transplant and the longer theirfollow-up after transplant. Similarly, an analysis compa-
ring the graft survival of kidney transplants in Common-
wealth countries (i.e., Canada, Australia, and the U.K.) vs.
the U.S. showed that the former had comparable 5- and
10-year graft survival rates, whereas the U.S. rate was sig-
nificantly lower at both time points [6]. It was hypo-
thesized that this observed difference in graft survival is at
least partly driven by U.S. Medicare’s limited coverage of
immunosuppressive medications.
Other areas of transplant research using CORR include
an evaluation of centre effects in kidney transplantation
[7], the incidence of cancer and ESKD among heart and
liver transplant recipients [8-10], patient survival after
kidney allograft failure [11-13], pediatric kidney trans-
plant outcomes [14-17], access to kidney transplantation
[18-20], and an assessment of misattributed paternity in
living kidney donors [21]. These studies highlight the po-
tential power of a national transplant registry in describing
the epidemiology of solid organ transplantation (and
related conditions), testing research hypotheses, and sup-
porting the development of sound health policy. With im-
provements in data capture, completeness, and quality (as
well as stronger engagement of key stakeholders), CORR
has the potential to become an indispensible resource for
patients, clinicians, researchers, and policy-makers, similar
to other renal and transplant registries throughout the
world (e.g., United States Renal Data System, Australia
and New Zealand Dialysis and Transplant Registry).
A description of the CORR data request process can
be found here (Additional file 2).
Future directions
In the near future, CORR will be changing from paper-
based data submissions to an entirely electronic-based
submission strategy. The goal is to transition to a paper-
less approach starting with the 2015 data submission
cycle. For centres that cannot use the standardized elec-
tronic submission specifications geared towards existing
databases (such as the one used by the Ontario Renal
Network), a web-based data entry solution that will
allow data capture similar to the current data reporting
forms is being developed. Comprehensive communica-
tion and training strategies are also concurrently being
developed. Electronic data submissions will improve the
efficiency, accuracy, and completeness of data collection,
as well as increase data privacy and security.
Another important issue for CORR will be its ongoing
relationship with Canadian Blood Services and their
Canadian Transplant Registry (CTR). As the CTR
evolves to become the main source for national data on
organ donation and transplantation, CORR will continue
to assess and re-evaluate the scope of its data holdings
and develop appropriate strategies to continue to serve
its stakeholders. One possibility will be to exclusively
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ation and potentially expand its data holdings to include
important clinical events (e.g., acute rejection episodes),
immunosuppressive drug regimens, and transplant tou-
rism. An ongoing interaction between the CTR and
CORR is essential to ensure that the full journey of a
kidney patient (which commonly includes kidney trans-
plantation) is well represented in the data holdings of
both registries. At this time, CORR/CIHI is working with
Canadian Blood Services to support and engage in the
evolution of the CTR (including a comprehensive review
and standardization of data elements to be captured in the
CTR) and progress on this issue is being followed with
great interest by the renal and transplant communities.
Conclusion
CORR is an important source of information on the status
of solid organ transplantation in Canada. It has and con-
tinues to provide its stakeholders with a national perspec-
tive on organ donation activity, the number/characteristics
of organ donors and transplant candidates, and the long-
term outcomes of solid organ transplant recipients. It is
used for epidemiologic and health services research that
contributes to improving clinical practice and informing
the development of health policy in transplantation. CORR
is an example of the power of registries for the surveillance
and advancement of patient care in complex health care
arenas such as transplantation. The importance of registry
data in monitoring and improving care for Canadian solid
organ transplant candidates/recipients cannot be over-
stated.
Additional files
Additional file 1: Supplemental Appendix.
Additional file 2: Data Request Process.
Abbreviations
CIHI: Canadian Institute for Health Information; CORR: Canadian Organ
Replacement Register; CTR: Canadian Transplant Registry; ESKD: End-stage
kidney disease; DCD: Donation after cardio-circulatory death;
NDD: Neurological determination of death; OPO: Organ procurement
organization; PMP: Per million population; VAD: Ventricular assist device.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Study concept and design: SJK. Acquisition of data: SJK, JW, GW. Analysis and
interpretation of data: SJK, SSAF, JK, LMM, SWK, SMS, LGS, DHK, KY, GW, JW,
FI, ES, JSG. Drafting of the manuscript: SJK. Critical revision of the manuscript
for important intellectual content: SJK, SSAF, JK, LMM, SWK, SMS, LGS, DHK,
KY, GW, JW, FI, ES, JSG. Statistical analysis: FI, ES. Administrative, technical, or
material support: SJK, JW, GW. Study supervision: SJK. All authors read and
approved the final manuscript.
Acknowledgements
CORR would not exist without the voluntary participation of all the dialysis
units, transplant programs, and organ procurement organizations acrossCanada. A special thanks the work done by the numerous members of the
participating professional societies who have served on the CORR Board of
Directors over the last 25 years.
Author details
1Department of Medicine, Division of Nephrology, University of Toronto, 585
University Avenue, 11-PMB-129, Toronto, ON M5G 2 N2, Canada.
2Multi-Organ Transplant Program, University Health Network, Toronto, ON,
Canada. 3Department of Medicine, Division of Nephrology, University of
Saskatchewan, Saskatoon, SK, Canada. 4Department of Medicine, Division of
Nephrology, Western University, London, ON, Canada. 5Department of
Medicine, Division of Nephrology, University of Alberta, Edmonton, AB,
Canada. 6Department of Pediatrics, Division of Nephrology, University of
Calgary, Calgary, AB, Canada. 7Department of Medicine, Division of
Respirology, University of Toronto, Toronto, ON, Canada. 8Department of
Medicine, Division of Cardiology, University of Alberta, Edmonton, AB,
Canada. 9Donation and Transplantation, Canadian Blood Services, Ottawa,
ON, Canada. 10Canadian Institute for Health Information, Toronto, ON,
Canada. 11Department of Medicine, Division of Nephrology, University of
British Columbia, Vancouver, BC, Canada.
Received: 3 September 2014 Accepted: 18 November 2014References
1. Moist LM, Fenton S, Kim SJ, Gill JS, Ivis F, de Sa E, Wu J, Al-Jaishi A, Sood M,
Klarenbach SW, Hemmelgarn B, Kappel JE: Canadian organ replacement
register (CORR): reflecting the past and embracing the future. Can J
Kidney Health Dis 2014, 1:26.
2. Canadian Institute for Health Information: Canadian Organ Replacement
Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2003
to 2012. Ottawa, ON: CIHI; 2014.
3. Call to Action: A strategic Plan to Improve Organ and Tissue Donation and
Transplantation Performance for Canadians. Ottawa, ON: Canadian Blood
Services; 2011.
4. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED,
Miller MA, Baldwin T, Young JB: Sixth INTERMACS annual report: a
10,000-patient database. J Heart Lung Transplant 2014, 33(6):555–564.
5. Kim SJ, Schaubel DE, Fenton SS, Leichtman AB, Port FK: Mortality after
kidney transplantation: a comparison between the United States and
Canada. Am J Transplant 2006, 6(1):109–114.
6. Gill JS, Tonelli M: Penny wise, pound foolish? Coverage limits on
immunosuppression after kidney transplantation. N Engl J Med 2012,
366(7):586–589.
7. Kim SJ, Schaubel DE, Jeffery JR, Fenton SS: Centre-specific variation in
renal transplant outcomes in Canada. Nephrol Dial Transplant 2004,
19(7):1856–1861.
8. Alam A, Badovinac K, Ivis F, Trpeski L, Cantarovich M: The outcome of
heart transplant recipients following the development of end-stage renal
disease: analysis of the Canadian Organ Replacement Register (CORR).
Am J Transplant 2007, 7(2):461–465.
9. Jiang Y, Villeneuve PJ, Fenton SS, Schaubel DE, Lilly L, Mao Y: Liver
transplantation and subsequent risk of cancer: findings from a Canadian
cohort study. Liver Transpl 2008, 14(11):1588–1597.
10. Jiang Y, Villeneuve PJ, Wielgosz A, Schaubel DE, Fenton SS, Mao Y: The
incidence of cancer in a population-based cohort of Canadian heart
transplant recipients. Am J Transplant 2010, 10(3):637–645.
11. Knoll G, Muirhead N, Trpeski L, Zhu N, Badovinac K: Patient survival
following renal transplant failure in Canada. Am J Transplant 2005,
5(7):1719–1724.
12. Perl J, Hasan O, Bargman JM, Jiang D, Na Y, Gill JS, Jassal SV: Impact of
dialysis modality on survival after kidney transplant failure. Clin J Am Soc
Nephrol 2011, 6(3):582–590.
13. Rao PS, Schaubel DE, Saran R: Impact of graft failure on patient survival
on dialysis: a comparison of transplant-naive and post-graft failure
mortality rates. Nephrol Dial Transplant 2005, 20(2):387–391.
14. Samuel SM, Foster BJ, Tonelli MA, Nettel-Aguirre A, Soo A, Alexander RT,
Crowshoe L, Hemmelgarn BR, Pediatric Renal Outcomes Canada Group:
Dialysis and transplantation among Aboriginal children with kidney
failure. CMAJ 2011, 183(10):E665–E672.
Kim et al. Canadian Journal of Kidney Health and Disease 2014, 1:31 Page 9 of 9
http://www.cjkhd.org/content/1/1/3115. Samuel SM, Hemmelgarn B, Nettel-Aguirre A, Foster B, Soo A, Alexander RT,
Tonelli M, Pediatric Renal Outcomes Canada Group: Association between
residence location and likelihood of transplantation among pediatric
dialysis patients. Pediatr Transplant 2012, 16(7):735–741.
16. Samuel SM, Nettel-Aguirre A, Hemmelgarn BR, Tonelli MA, Soo A, Clark C,
Alexander RT, Foster BJ, Pediatric Renal Outcomes Canada Group: Graft
failure and adaptation period to adult healthcare centers in pediatric
renal transplant patients. Transplantation 2011, 91(12):1380–1385.
17. Samuel SM, Tonelli MA, Foster BJ, Alexander RT, Nettel-Aguirre A, Soo A,
Hemmelgarn BR, Pediatric Renal Outcomes Canada Group: Survival in
pediatric dialysis and transplant patients. Clin J Am Soc Nephrol 2011,
6(5):1094–1099.
18. Schaubel DE, Stewart DE, Morrison HI, Zimmerman DL, Cameron JI, Jeffery
JJ, Fenton SS: Sex inequality in kidney transplantation rates. Arch Intern
Med 2000, 160(15):2349–2354.
19. Tonelli M, Klarenbach S, Manns B, Culleton B, Hemmelgarn B, Bertazzon S,
Wiebe N, Gill JS, Alberta Kidney Disease Network: Residence location and
likelihood of kidney transplantation. CMAJ 2006, 175(5):478–482.
20. Yeates KE, Schaubel DE, Cass A, Sequist TD, Ayanian JZ: Access to renal
transplantation for minority patients with ESRD in Canada. Am J Kidney
Dis 2004, 44(6):1083–1089.
21. Young A, Kim SJ, Gibney EM, Parikh CR, Cuerden MS, Horvat LD, Hizo-Abes P,
Garg AX, Donor Nephrectomy Outcomes Research (DONOR) Network:
Discovering misattributed paternity in living kidney donation: prevalence,
preference, and practice. Transplantation 2009, 87(10):1429–1435.
doi:10.1186/s40697-014-0031-8
Cite this article as: Kim et al.: Organ donation and transplantation in
Canada: insights from the Canadian Organ Replacement Register.
Canadian Journal of Kidney Health and Disease 2014 1:31.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
